Home › Merkel Cell Carcinoma › California
Merkel Cell Carcinoma clinical trials in California
5 studies for Merkel Cell Carcinoma are looking for participants at sites in California.
Cities in California
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
- City of Hope, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05583708Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Precision NextGen Oncology, Beverly Hills
- OPN Healthcare, Inc, Glendale
- University of Southern California, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- UC San Diego Moores Cancer Center, La Jolla
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05896839Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
- USC Norris Comprehensive Cancer Center, Los Angeles
- University of California San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco
- Stanford Health Care - Skin Cancer Program, Stanford
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06947928A Beta-only IL-2 ImmunoTherapY Study
- Sharp Memorial Hospital, San Diego
- Providence Saint John's Health Center, Santa Monica
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 9, 2025 · NCT05086692From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.